Biomarker Discovery in Drug Development

Biomarker discovery is integral to advancing drug development, particularly for personalized medicine. Research from 2019 to 2024 has focused on identifying biomarkers that can predict disease progression and response to treatment. Advances in genomics, proteomics, and metabolomics have paved the way for more targeted therapies, especially in oncology and rare diseases. Biomarkers are being used to refine patient selection, enhance clinical trial efficiency, and accelerate regulatory approval processes. These advancements are improving drug efficacy, reducing side effects, and enabling more precise treatments tailored to individual genetic and molecular profiles.

    Related Conference of Biomarker Discovery in Drug Development

    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Aix-en-Provence, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Biomarker Discovery in Drug Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in